Semma Therapeutics Announces Pre-Clinical Proof-of-Concept in Two Lead Programs in Type 1 Diabetes July 1, 2019
Apellis Pharmaceuticals Completes Enrollment of Phase 3 APL-2 (pegcetacoplan) Head-to-Head Study in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab June 27, 2019
Kyruus and Brandify Form Partnership to Help Health Systems Boost Brand Visibility and Patient Acquisition Online June 18, 2019
Compass Therapeutics Announces Issuance of Composition of Matter and Method Patents Covering Its Lead Immuno-oncology Candidate, CTX-471 June 17, 2019
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at 2019 ASCO and EHA Annual Meetings June 17, 2019
Innovusion Announces Its High-Resolution Image-Grade LiDAR System “Cheetah”, Enabling the Safest Performance in the Vehicle Mobility Industry June 14, 2019
Signaling Industry-Wide Shift to Integrated Mental Health, Quartet Announces Capital Raise and Strategic Partnership with Leading Medicaid Provider June 13, 2019